Ventana Biotech, Inc.
VNTA · OTC
12/31/2024 | 12/31/2023 | 12/31/2021 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $430 | $45,178 | $31,636 | $12,693 |
| - Cash | $62 | $34 | $0 | $0 |
| + Debt | $110 | $105 | $0 | $0 |
| Enterprise Value | $478 | $45,249 | $31,636 | $12,693 |
| Revenue | $41 | $32 | $0 | $0 |
| % Growth | 29.9% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | – | – |
| EBITDA | $21 | $18 | -$7 | -$0 |
| % Margin | 50.3% | 58% | – | – |
| Net Income | $20 | $17 | -$82 | -$5 |
| % Margin | 48.1% | 54.3% | – | – |
| EPS Diluted | 0 | 0 | -0.003 | -0.001 |
| % Growth | 33.3% | 111.5% | -160% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |